MENU
+Compare
SHPMY
Stock ticker: OTC
AS OF
Apr 11 closing price
Price
$6.83
Change
-$0.85 (-11.07%)
Capitalization
9.5B

SHPMY stock forecast, quote, news & analysis

Shanghai Pharmaceuticals is the second-largest medical distributor in China by revenue... Show more

SHPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for SHPMY with price predictions
Jul 02, 2025

SHPMY in upward trend: 10-day moving average moved above 50-day moving average on June 24, 2025

The 10-day moving average for SHPMY crossed bullishly above the 50-day moving average on June 24, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

SHPMY moved above its 50-day moving average on June 24, 2025 date and that indicates a change from a downward trend to an upward trend.

Bearish Trend Analysis

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.716) is normal, around the industry mean (7.892). P/E Ratio (8.389) is within average values for comparable stocks, (29.460). Projected Growth (PEG Ratio) (2.467) is also within normal values, averaging (4.521). Dividend Yield (0.045) settles around the average of (0.032) among similar stocks. P/S Ratio (0.204) is also within normal values, averaging (35.215).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SHPMY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SHPMY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock worse than average.

A.I.Advisor
published Dividends

SHPMY paid dividends on November 12, 2024

Shanghai Pharmaceuticals Holdings Co., Ltd. SHPMY Stock Dividends
А dividend of $0.06 per share was paid with a record date of November 12, 2024, and an ex-dividend date of September 19, 2024. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are McKesson Corp (NYSE:MCK).

Industry description

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

Market Cap

The average market capitalization across the Medical Distributors Industry is 10.22B. The market cap for tickers in the group ranges from 494.39K to 70.55B. MCK holds the highest valuation in this group at 70.55B. The lowest valued company is SNYR at 494.39K.

High and low price notable news

The average weekly price growth across all stocks in the Medical Distributors Industry was 2%. For the same Industry, the average monthly price growth was 8%, and the average quarterly price growth was -2%. SNYR experienced the highest price growth at 30%, while ZYXI experienced the biggest fall at -8%.

Volume

The average weekly volume growth across all stocks in the Medical Distributors Industry was 22%. For the same stocks of the Industry, the average monthly volume growth was 8% and the average quarterly volume growth was 46%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 62
Price Growth Rating: 54
SMR Rating: 81
Profit Risk Rating: 81
Seasonality Score: -25 (-100 ... +100)
View a ticker or compare two or three
SHPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry MedicalDistributors

Profile
Fundamentals
Details
Industry
N/A
Address
No. 200 Taicang Road
Phone
+86 2163730908
Employees
47877
Web
https://www.sphchina.com